What do championship sports teams and successful research institutions have in common? In the season finale of Beyond the Endpoint, Dr. Adrian Hernandez joins hosts Manesh Patel and Emily O’Brien to break down what clinical research institutions can learn from their counterparts on the court. From basketball dynasties to resilient mindsets, Dr. Her…

In this new episode of the Beyond the Endpoint series, “Beyond the Headlines,” hosts Emily O’Brien and Manesh Patel break down what’s you should know about these trending medical topics. From hype to headlines—get clinical insight that goes deeper. Access resources related to this episode https://dcri.org/blog/ep-9-beyond-headlines187880…

Why do people volunteer for clinical trials — and what should they know before doing so? In this episode of Beyond The Endpoint, we explore common questions, reasons, and myths about clinical trial participation. Hosts Manesh Patel and Emily O’Brien talk with guest Krista Camuglia, a Research Practice Manager with the Duke Heart Center Clinical Res…

In this episode, cancer survivor Katie Ortman-Doble opens up about her journey through clinical research and why she chose to participate. Hosts Emily O’Brien and Manesh Patel, joined by Jenny Cook, talk about the life-saving potential of clinical trials and the real impact they have on patients and science. Hear Katie’s inspiring story and the rea…

In this episode of Beyond the Endpoint, former FDA commissioner Dr. Robert Califf joins hosts Manesh Patel and Emily O’Brien to discuss critical challenges shaping the future of patient care. From misinformation to regulatory science to the financialization of healthcare, Dr. Califf has unique insight into the evolving healthcare landscape and the …

Ozempic curbing alcohol cravings, ADHD linked to shorter life expectancy, and an NBA rising star diagnosed with DVT—what does the science actually say? In this first episode of Beyond the Headlines, a new Beyond the Endpoint series, hosts Emily O’Brien and Manesh Patel break down the research behind these trending stories.Access resources related t…

Smartwatches, fitness trackers, and health data—how are wearables reshaping clinical research? In this episode, Dr. Marat Fudim joins us for an insightful discussion on how wearable technology is shaping the way we monitor health and conduct research. Topics include: • Are wearables improving patient care or just tracking steps? • How do researcher…

In this episode of Beyond the Endpoint, Emily O’Brien and Manesh Patel sit down with Leslie Curtis, former senior FDA policy advisor, to explore the FDA’s role in balancing science, public health, and regulation, along with how political transitions influence clinical research, healthcare funding, and the approval process for new treatments.🔗 Acces…

Reducing hypertension risk isn’t just about cutting salt. This week on Beyond The Endpoint, Emily O’Brien, Manesh Patel, and Jenny Cook talk with Dr. Dhruv Kazi about the complex public health battle against hypertension. From interventions to strategies for patient and physician adherence, this episode covers scalable solutions to change the futur…

In this episode of "Beyond the Endpoint," hosts Emily O'Brien and Manesh Patel are joined by guest host Jenny Cook to discuss grief among healthcare providers with Tony Galanos, a researcher and physician at the Duke University School of Medicine. Galanos — "Dr. G" as he's called around Duke — shares insights from his 12-year program helping other …

Inviting Our Colleagues To Participate In DCRI On Record by Duke Clinical Research InstituteBy Duke Clinical Research Institute

John Shepherd And Michele Nolen by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Duke IBD Podcast Series: IBD and Nutrition by Duke Clinical Research InstituteBy Duke Clinical Research Institute

IBD Podcast with Dr. Jane Onken by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Patient Perspective Nutrition And Diet In Perioperative Recovery by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Nutrition In ERAS: " A Call For Clinical Trials" by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Data, Innovation & Guidelines in Gastroenterology – Deborah Fisher, MD by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Sunil Rao at TCT 2018: Meeting Highlights and the #RadialFirst Journey by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Renato Lopes at TCT 2018: SECURE-PCI and Timing for Statin Dosing by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Jennifer Rymer at TCT 2018: Aborted TAVR Procedures and Same-Day Discharge for PCI by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Nutrition in Surgery – The Clinician’s Perspective by Duke Clinical Research InstituteBy Duke Clinical Research Institute

The Role of the Dietician in Perioperative Nutrition Screening and Care by Duke Clinical Research InstituteBy Duke Clinical Research Institute

Perioperative Nutrition Optimization Clinics: The Future of Perioperative Care by Duke Clinical Research InstituteBy Duke Clinical Research Institute

The Role of Nutrition in 'Strong for Surgery' by Duke Clinical Research InstituteBy Duke Clinical Research Institute

What are clinical trials? Who should participate in them? And why are they important? In this episode of Science is the Best Medicine, Abhinav Sharma talks to Harvard’s Eugene Braunwald, MD, a cardiologist who’s been a firsthand witness to more than 50 years of clinical trials.By Duke Clinical Research Institute

Duke’s Mona Fiuzat, PhD, talks with Abhinav Sharma about how scientific discoveries are translated to usable treatments and how the U.S. Food and Drug Administration really works.By Duke Clinical Research Institute

Cardiologist Joseph Hill, MD, PhD, editor-in-chief of Circulation, discusses what it’s like to run a peer-reviewed journal and how medical discoveries are disseminated in the age of information overload.By Duke Clinical Research Institute

Medicare, Obamacare, rising costs, and preexisting conditions: The controversy over health care in the United States rages on in Congress and online. In this episode Mark McClellan, director of the Margolis Center for Health Policy and former U.S. Food and Drug Administration commissioner, discusses the complexities of healthcare policy.…

Robert Lefkowitz, MD, won the Nobel Prize for Chemistry in 2012 for his groundbreaking work on the proteins known as receptors. That research has since influenced the development of a wide variety of drugs including antihistamines, ulcer drugs, and beta blockers. In this episode of the podcast, he discusses his research, his family, and the path th…

Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result, according to the Centers for Disease Control. These so-called "superbugs" represent one of the major public health threats facing the world today. In this episode, Ephraim Tsalik, MD, PhD, discus…

Chronic kidney disease (CKD) is among the most common diseases in the United States, affecting approximately 14 percent of the adult population. The disease, which often goes unnoticed until its advanced stages, can increase the risk of heart attack, stroke, or other serious medical conditions. In this episode of Science is the Best Medicine, Abhin…